ProfileGDS4459 / ENSG00000137309
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 82% 69% 60% 81% 70% 60% 59% 46% 61% 57% 75% 54% 41% 74% 55% 67% 54% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.1782
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.1669
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.8460
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.9281
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.370
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.7660
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.8359
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.1946
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.8561
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.7357
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.6175
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.5354
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.0841
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.3774
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.655
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.0267
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.5254